Skip to content
DataLookout
Menu

NCT07936656

Probiotic Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Incidence of Antibiotic-Associated Diarrhea (AAD)
Timeframe: 15 days

Secondary (9)

Incidence of children with at least one episode of diarrhea
Number of daily defecations
Number of days with diarrhea
Stool consistency
Abdominal pain During and After Antibiotic Treatment
Show 4 moreShow less
Nausea During and After Antibiotic Treatment
Vomiting During and After Antibiotic Treatment
Treatment compliance
Adverse events

Arms and interventions

Brevicillin® gocce (Bifidobacterium breve PRL2020)Experimental

Participants will receive Brevicillin® gocce, a probiotic food supplement containing Bifidobacterium breve PRL2020 (LMG S-32458), alongside standard antibiotic therapy with amoxicillin or amoxicillin/clavulanic acid. Dosage and administration: 5 drops, 2-3 times per day (depending on antibiotic dosing schedule), administered during the antibiotic treatment period (6-10 days). After completion of antibiotic therapy, participants will enter a follow-up period until day 15 without probiotic administration.

PlaceboPlacebo comparator

Participants will receive a placebo formulation matched in appearance, packaging, and dosing schedule to Brevicillin® gocce, administered alongside standard antibiotic therapy with amoxicillin or amoxicillin/clavulanic acid. The placebo will be given at the same frequency (5 drops, 2-3 times per day) and duration as the experimental product during the antibiotic treatment period (6-10 days). After antibiotic completion, participants will enter a follow-up period until day 15 without placebo administration.

Dietary supplements: Brevicillin® gocce (Bifidobacterium breve PRL2020)

Other: Placebo (matching oil drops)

Sites

20 sites in 1 country